• Research Technician I-III, Immunotherapy

    Job ID
    11351
    Type
    Regular Full-Time
    Company
    Fred Hutchinson Cancer Research Center
    Location
    US-WA-Seattle
    Category
    Laboratory Research Sciences
  • Overview

    Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.Careers Start Here.

     

    The Program of Immunology and Clinical Research Division is seeking an experienced technician to work in the pre-clinical research laboratory environment.

    Responsibilities

    The Program in Immunology in the Clinical Research Division is looking for a highly motivated individual to support the development of immunotherapy for cancer. This individual will be directly involved in isolating lymphocytes from blood and generating human T cell lines and clones. S/he will have the opportunity to work with a variety of cutting-edge cellular and molecular research techniques. S/he will assist with processing of patient samples from research protocols. This person will be responsible for maintaining meticulous records and organizing and reporting on experimental results.

    Qualifications

    Minimum Qualifications:

    Tech I Level: Bachelor’s degree in a biological science and some bench research experience with tissue culture and/or molecular biology outside of coursework is essential.

    Tech II Level: All qualifications of the Tech I level with at least two years of professional lab experience in a related field with relevant techniques. A Master’s degree in a related field can substitute for two years of professional lab experience.

    Tech III Level: All qualifications of the Tech I level with at least five years of professional lab experience in a related field with relevant techniques. A Master’s degree in a related field can substitute for two years of professional lab experience. A successful candidate should have a demonstrated ability to independently manage research projects with minimal supervision.

     

    Preferred Qualifications:

    Experience in immunologic techniques such as cell separation and selection, flow cytometry, chromium release assays, ELISPOT and ELISA is desirable although not required. Experience in specific molecular techniques such as PCR, DNA sequencing, western blotting, molecular cloning, viral vector construction is also desirable. Individuals with an interest in a long-term career in biomedical research and/or medicine are especially encouraged to apply.

    Our Commitment to Diversity

    We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at escmail@fredhutch.org or by calling 206-667-4700.

    Options

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed